Rewriting the Rules of Pathology: Diagnexia's Shift from Service Provider to Vital Partner

Having worked in and alongside histopathology departments for several years, I’ve seen the incredible dedication of teams under relentless pressure. I’ve sat with service leads staring down weeks of case backlogs, watched departments scramble to fill persistent vacancies, and listened to the quiet frustration when traditional outsourcing models didn’t quite meet the need. Pathology is the backbone of so much of modern medicine, yet it often runs in the background, essential but under-resourced, quietly absorbing ever-increasing demand.

Written by
Mike Mayoll
Published on
May 29, 2025
Category
Diagnexia
"The greatest danger in times of turbulence is not the turbulence—it is to act with yesterday’s logic."
— Peter Drucker

Having worked in and alongside histopathology departments for several years, I’ve seen the incredible dedication of teams under relentless pressure. I’ve sat with service leads staring down weeks of case backlogs, watched departments scramble to fill persistent vacancies, and listened to the quiet frustration when traditional outsourcing models didn’t quite meet the need. Pathology is the backbone of so much of modern medicine, yet it often runs in the background, essential but under-resourced, quietly absorbing ever-increasing demand.

What I noticed over time was that outsourcing, when used, was rarely part of a proactive plan. It was reactive—introduced when turnaround times were at risk, when staff were off sick or leaving, when there was simply no other option. And for good reason: historically, many outsourced reporting services felt disconnected from local teams. They weren’t always consistent, and they didn’t always align with how departments worked on the ground. There was understandable scepticism.

That’s why it’s been so rewarding for me to see how Diagnexia has evolved. I’ve had the privilege of watching it grow from a single-partner provider into a respected and trusted partner across the UK. And that growth hasn’t come from a flashy launch or big promotional campaign. It’s come from focusing on what actually matters to clinical teams.

Diagnexia doesn’t try to be everything to everyone. Instead, it was built with a very clear aim: to be a subspecialist-led extension of the departments it supports. That means integrating directly into existing workflows, mirroring the standards and practices of NHS services, and working in a way that feels less like outsourcing and more like collaboration.

A huge part of that is digital. Diagnexia’s infrastructure allows for seamless case submission, tracking, and reporting, but what really stands out is that it’s been developed in-house. This isn’t a generic tech platform forced to fit into healthcare. It’s a system designed specifically for pathologists, by people who understand the nuances of the work. It reduces friction, speeds up processes, and gives departments real-time visibility, which builds confidence and trust.

And then there’s the AI. I know AI can be an overused term, but at Diagnexia, it’s not a buzzword. It’s quietly, meaningfully built into how we support both laboratories and pathologists. From streamlining repetitive lab tasks to intelligent triaging and diagnostic support, our AI tools are designed in-house to do one thing: help teams work more efficiently without ever compromising on quality. Because we develop these tools ourselves, they’re fine-tuned to our users' needs and can evolve with them, rather than being locked into rigid third-party systems.

Of course, no matter how good the technology is, the people delivering the service make all the difference. One of the things I hear again and again from departments we work with is how valuable the responsiveness and clarity of communication is. Diagnexia isn’t just about sending reports, it’s about being available, involved, and aligned with clinical priorities. Whether it’s following up on a complex case or participating in remote MDTs, our teams are present and engaged.

Another area where we’ve deliberately focused is capacity. Too many outsourcing providers in the past simply couldn’t scale when it mattered. Diagnexia took a different approach, building a robust network of highly experienced subspecialist pathologists from the outset. That’s made it possible to step in quickly, whether a department is dealing with planned leave, unfilled posts, or unexpected surges in demand. And we’re not just filling gaps, we’re helping departments stay on the front foot.

Looking back, I understand why some clinicians were cautious about external reporting. For years, the sector didn’t offer a compelling alternative. But that’s what makes what we’re doing now feel different, and necessary. With the right team, the right technology, and a clear commitment to quality, it is possible to offer a level of service that doesn’t just solve problems, but actively improves how departments function.

The challenges facing pathology aren’t going away. But we don’t have to keep relying on yesterday’s solutions. I believe strongly that we need smarter, more flexible models of working, ones that protect quality, support staff, and most importantly, improve patient outcomes.

At Diagnexia, that’s what we’re striving to deliver. Not just a way to catch up, but a way to move forward.

Written by

Mike Mayoll

Regional Sales Manager - South UK
mike.mayoll@diagnexia.com
Share this post

I am the text that will be copied.